Stock GLS GLENMARK LIFE SCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Glenmark Life Sciences Limited Bombay S.E.

Equities

GLS

INE03Q201024

Market Closed - Bombay S.E.
Other stock markets
 11:00:48 02/05/2024 BST 		5-day change 1st Jan Change
841.2 INR +1.46% Intraday chart for Glenmark Life Sciences Limited +1.68% +28.02%
04-25 Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024
04-25 Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Glenmark Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Glenmark Life Sciences Limited Announces Resignation of Gita Nayyar as Non-Executive, Independent Director
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.
Glenmark Life Sciences Limited Announces Board Resignations, Effective March 6, 2024
Nirma Limited completed the acquisition of 0.000738% stake in Glenmark Life Sciences Limited.
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO
Glenmark Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Paracetamol maker Granules India posts marginal rise in Q3 profit
Glenmark Life Sciences Announces Another CDMO Deal
India's Glenmark Pharma posts Q2 loss on exceptional legal costs
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand
India's Glenmark Life Sciences posts Q2 profit rise on API boost
Glenmark Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Glenmark Life Sciences Limited Declares Interim Equity Dividend for the Financial Year 2023-24, Payable on or After October 23, 2023
Indian paracetamol maker Valiant Laboratories lists at 16% premium
Glenmark Life Sciences Limited Approves Interim Dividend for the Financial Year 2022-23
Glenmark Pharmaceuticals to Divest Majority Stake in Glenmark Life Sciences for INR56.5 Billion
INDIA STOCKS-Indian shares set for subdued open as Fed angst weighs
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLS Stock
  4. GLS Stock
  5. News Glenmark Life Sciences Limited
  6. Other languages